High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials
Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Dirk J. de Jong(Radboud University Nijmegen), M T Milou Kampschreur(Radboud University Nijmegen), Martijn G.H. van Oijen(University Medical Center Utrecht), Joost P.H. Drenth(Amsterdam Neuroscience)
Cited by 57
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680